

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.66711450 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 5.96115043 |
| 3 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.79277719 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.68968973 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.68968973 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.68968973 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.68968973 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.68968973 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.68968973 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.36160882 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.29210544 |
| 12 | regulation of vitamin metabolic process (GO:0030656) | 5.18245806 |
| 13 | response to peptidoglycan (GO:0032494) | 5.12540973 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.69991855 |
| 15 | regulation of heat generation (GO:0031650) | 4.60395736 |
| 16 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.55782983 |
| 17 | superoxide anion generation (GO:0042554) | 4.45215280 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.42141918 |
| 19 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.32628470 |
| 20 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.30001808 |
| 21 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.22671219 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.14595177 |
| 23 | respiratory burst (GO:0045730) | 4.13823551 |
| 24 | response to host immune response (GO:0052572) | 4.10814734 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.10814734 |
| 26 | negative regulation of growth of symbiont in host (GO:0044130) | 4.10744583 |
| 27 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.10744583 |
| 28 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.10744583 |
| 29 | regulation of growth of symbiont in host (GO:0044126) | 4.10744583 |
| 30 | reactive oxygen species biosynthetic process (GO:1903409) | 4.07473888 |
| 31 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.97250259 |
| 32 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.92626262 |
| 33 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.91442987 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.90330954 |
| 35 | glycosphingolipid catabolic process (GO:0046479) | 3.89318114 |
| 36 | positive regulation of macrophage cytokine production (GO:0060907) | 3.86946427 |
| 37 | monocyte chemotaxis (GO:0002548) | 3.85894125 |
| 38 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.80428824 |
| 39 | regulation of prostaglandin secretion (GO:0032306) | 3.80236049 |
| 40 | positive regulation of prostaglandin secretion (GO:0032308) | 3.79872383 |
| 41 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.79077942 |
| 42 | macrophage activation (GO:0042116) | 3.78243569 |
| 43 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.77693404 |
| 44 | T-helper 1 type immune response (GO:0042088) | 3.76166252 |
| 45 | negative regulation of interleukin-17 production (GO:0032700) | 3.73903814 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.73588722 |
| 47 | positive regulation of respiratory burst (GO:0060267) | 3.69714910 |
| 48 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.69308509 |
| 49 | granulocyte activation (GO:0036230) | 3.68998052 |
| 50 | regulation of podosome assembly (GO:0071801) | 3.68296299 |
| 51 | response to host (GO:0075136) | 3.66813135 |
| 52 | response to host defenses (GO:0052200) | 3.66813135 |
| 53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.66813135 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.62754537 |
| 55 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.62328938 |
| 56 | detection of biotic stimulus (GO:0009595) | 3.60869034 |
| 57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.60622308 |
| 58 | positive regulation of heat generation (GO:0031652) | 3.58005209 |
| 59 | purine ribonucleotide transport (GO:0015868) | 3.57757191 |
| 60 | oligosaccharide catabolic process (GO:0009313) | 3.57497970 |
| 61 | adenine nucleotide transport (GO:0051503) | 3.56593956 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.55262081 |
| 63 | neutrophil activation (GO:0042119) | 3.51765858 |
| 64 | leukocyte aggregation (GO:0070486) | 3.49673169 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.48960445 |
| 66 | glycolipid catabolic process (GO:0019377) | 3.46234819 |
| 67 | positive regulation of acute inflammatory response (GO:0002675) | 3.45460625 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.43068199 |
| 69 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.41479945 |
| 70 | regulation of macrophage cytokine production (GO:0010935) | 3.40640567 |
| 71 | microglial cell activation (GO:0001774) | 3.39561705 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 3.39071603 |
| 73 | regulation of chemokine biosynthetic process (GO:0045073) | 3.36880203 |
| 74 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.34976348 |
| 75 | regulation of fever generation (GO:0031620) | 3.34752998 |
| 76 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.32979576 |
| 77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30935356 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 3.28068238 |
| 79 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.26895939 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.26328809 |
| 81 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.25895632 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17442638 |
| 83 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.17064427 |
| 84 | positive regulation of chemokine production (GO:0032722) | 3.16767003 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.15567964 |
| 86 | germinal center formation (GO:0002467) | 3.15554905 |
| 87 | cellular extravasation (GO:0045123) | 3.15108924 |
| 88 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.14862134 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13196394 |
| 90 | positive regulation of mast cell degranulation (GO:0043306) | 3.13196394 |
| 91 | eosinophil chemotaxis (GO:0048245) | 3.12464281 |
| 92 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.11827058 |
| 93 | regulation of monocyte chemotaxis (GO:0090025) | 3.10953784 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 3.09762872 |
| 95 | neutrophil chemotaxis (GO:0030593) | 3.08959501 |
| 96 | positive regulation of interleukin-12 production (GO:0032735) | 3.08726075 |
| 97 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.08200008 |
| 98 | regulation of macrophage chemotaxis (GO:0010758) | 3.08005269 |
| 99 | ceramide catabolic process (GO:0046514) | 3.07722566 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.07594085 |
| 101 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.05231336 |
| 102 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04816794 |
| 103 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.03222374 |
| 104 | positive regulation of interleukin-6 production (GO:0032755) | 3.01848544 |
| 105 | neutrophil migration (GO:1990266) | 3.00579452 |
| 106 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.99830743 |
| 107 | response to protozoan (GO:0001562) | 2.99762725 |
| 108 | regulation of integrin activation (GO:0033623) | 2.99732981 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 2.98371018 |
| 110 | low-density lipoprotein particle clearance (GO:0034383) | 2.97713082 |
| 111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97373969 |
| 112 | cellular response to arsenic-containing substance (GO:0071243) | 2.97114958 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.97023248 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.95911510 |
| 115 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95435904 |
| 116 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94750309 |
| 117 | purine nucleotide transport (GO:0015865) | 2.94748677 |
| 118 | positive regulation of interleukin-10 production (GO:0032733) | 2.94010431 |
| 119 | cellular response to ethanol (GO:0071361) | 2.93078664 |
| 120 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.91612367 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91534005 |
| 122 | positive regulation of interferon-beta production (GO:0032728) | 2.91150925 |
| 123 | eosinophil migration (GO:0072677) | 2.90213095 |
| 124 | regulation of cholesterol storage (GO:0010885) | 2.90033358 |
| 125 | positive regulation of interleukin-2 production (GO:0032743) | 2.89695998 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89224020 |
| 127 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.88621526 |
| 128 | granulocyte chemotaxis (GO:0071621) | 2.87901317 |
| 129 | positive regulation of type 2 immune response (GO:0002830) | 2.86852551 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.86815025 |
| 131 | neutrophil mediated immunity (GO:0002446) | 2.86533195 |
| 132 | regulation of chronic inflammatory response (GO:0002676) | 2.85412360 |
| 133 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84912048 |
| 134 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.83759399 |
| 135 | regulation of interleukin-17 production (GO:0032660) | 2.83536220 |
| 136 | opsonization (GO:0008228) | 2.82000816 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.79462708 |
| 138 | cellular response to lipopolysaccharide (GO:0071222) | 2.79324005 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79289071 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.78782014 |
| 141 | negative regulation of lipid storage (GO:0010888) | 2.78603494 |
| 142 | regulation of interleukin-6 production (GO:0032675) | 2.78532772 |
| 143 | cellular response to molecule of bacterial origin (GO:0071219) | 2.77986217 |
| 144 | I-kappaB phosphorylation (GO:0007252) | 2.77125156 |
| 145 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.76476552 |
| 146 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.76062090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.05600510 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.17066311 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.23498569 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.94840616 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.92638291 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.92047828 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.78545625 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.38405768 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22048127 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20327762 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.10313034 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.06155963 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95619309 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69532331 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48267044 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40688788 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06830655 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97319065 |
| 19 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.96444202 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.93727067 |
| 21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92416926 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88154256 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87164187 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82079373 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81678097 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.81233707 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80323250 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73513170 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69995281 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69828910 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66949554 |
| 32 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61870340 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59960556 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56596556 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54535213 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49316166 |
| 37 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47098653 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46680515 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44800634 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44355805 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42178503 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39826849 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39826849 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37669599 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36512511 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35819288 |
| 47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35646867 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35502105 |
| 49 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34059073 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33697198 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30650907 |
| 52 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28309208 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26919196 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23707883 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.23381720 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20680131 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20406693 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19307110 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17856838 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14802626 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10007648 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08439203 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07484304 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07135781 |
| 65 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06871128 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06840913 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06422903 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04911676 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04592904 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02409910 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02058416 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01773707 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01264517 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00780917 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99430099 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98937228 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98295554 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98221696 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96033396 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95759074 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95731154 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95645259 |
| 83 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94184411 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93617426 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92722195 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91931880 |
| 87 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91872194 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91373625 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88806035 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 0.87430854 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87113815 |
| 92 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86668866 |
| 93 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86668866 |
| 94 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86169426 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86047636 |
| 96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85872698 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 0.85348422 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85277603 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85044580 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84231247 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83618570 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83597564 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83364549 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83193552 |
| 105 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83086509 |
| 106 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81230254 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80321292 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80286373 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80282621 |
| 110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.79711959 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79279718 |
| 112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79135218 |
| 113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78750212 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78260701 |
| 115 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.78256475 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78042877 |
| 117 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77386676 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.77228847 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77172106 |
| 120 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76113162 |
| 121 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.75964973 |
| 122 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.75956879 |
| 123 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.74119648 |
| 124 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73107694 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72803930 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.72649533 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72120765 |
| 128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.71321793 |
| 129 | UTX_26944678_Chip-Seq_JUKART_Human | 0.71179403 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.70786010 |
| 131 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70098759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.21776559 |
| 2 | MP0009785_altered_susceptibility_to | 3.99140963 |
| 3 | MP0003436_decreased_susceptibility_to | 3.98037844 |
| 4 | MP0003303_peritoneal_inflammation | 3.67991780 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.66639193 |
| 6 | MP0002419_abnormal_innate_immunity | 3.49291515 |
| 7 | MP0003724_increased_susceptibility_to | 3.48202030 |
| 8 | MP0006082_CNS_inflammation | 3.14770951 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.02435629 |
| 10 | MP0004510_myositis | 3.00109301 |
| 11 | MP0005025_abnormal_response_to | 2.97178855 |
| 12 | MP0001790_abnormal_immune_system | 2.67005539 |
| 13 | MP0005387_immune_system_phenotype | 2.67005539 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.53878623 |
| 15 | MP0009764_decreased_sensitivity_to | 2.51805889 |
| 16 | MP0005671_abnormal_response_to | 2.45346392 |
| 17 | * MP0002723_abnormal_immune_serum | 2.31629581 |
| 18 | MP0002254_reproductive_system_inflammat | 2.27056817 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.21033970 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.20991309 |
| 21 | MP0001800_abnormal_humoral_immune | 2.16211397 |
| 22 | MP0001819_abnormal_immune_cell | 2.09143826 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.04238186 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.03799761 |
| 25 | MP0003448_altered_tumor_morphology | 2.01729675 |
| 26 | MP0000685_abnormal_immune_system | 1.99537297 |
| 27 | MP0003075_altered_response_to | 1.91442453 |
| 28 | MP0001853_heart_inflammation | 1.88766357 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.84484253 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.80272264 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.77690546 |
| 32 | * MP0000343_altered_response_to | 1.77278512 |
| 33 | MP0005164_abnormal_response_to | 1.75365033 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.73576602 |
| 35 | MP0005166_decreased_susceptibility_to | 1.73270229 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.72286856 |
| 37 | MP0002405_respiratory_system_inflammati | 1.71510475 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.70572440 |
| 39 | MP0003136_yellow_coat_color | 1.66612165 |
| 40 | MP0004947_skin_inflammation | 1.63159892 |
| 41 | MP0000858_altered_metastatic_potential | 1.62468549 |
| 42 | * MP0008469_abnormal_protein_level | 1.52380217 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.51756233 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.49697426 |
| 45 | MP0003195_calcinosis | 1.46382840 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.45483978 |
| 47 | MP0009278_abnormal_bone_marrow | 1.45465014 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.39709663 |
| 49 | MP0000716_abnormal_immune_system | 1.36346313 |
| 50 | MP0002102_abnormal_ear_morphology | 1.35597139 |
| 51 | MP0005451_abnormal_body_composition | 1.34644836 |
| 52 | MP0004883_abnormal_blood_vessel | 1.34219846 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.32378800 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.31823180 |
| 55 | MP0002006_tumorigenesis | 1.29587169 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.26708626 |
| 57 | MP0003828_pulmonary_edema | 1.22788834 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.20363474 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.19718193 |
| 60 | MP0000920_abnormal_myelination | 1.19552346 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.18071164 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.18071164 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.14210685 |
| 64 | MP0000604_amyloidosis | 1.14136067 |
| 65 | MP0005310_abnormal_salivary_gland | 1.13874890 |
| 66 | MP0005390_skeleton_phenotype | 1.11326599 |
| 67 | MP0002398_abnormal_bone_marrow | 1.10993099 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.05672494 |
| 69 | MP0002429_abnormal_blood_cell | 1.04817769 |
| 70 | MP0003690_abnormal_glial_cell | 1.00687352 |
| 71 | MP0006054_spinal_hemorrhage | 0.98845017 |
| 72 | MP0000681_abnormal_thyroid_gland | 0.98337240 |
| 73 | MP0003045_fibrosis | 0.97986124 |
| 74 | MP0009763_increased_sensitivity_to | 0.96099223 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.95971451 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.94682444 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.93541266 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.91702947 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.88398384 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.88351978 |
| 81 | MP0002933_joint_inflammation | 0.87673033 |
| 82 | MP0001851_eye_inflammation | 0.87432954 |
| 83 | MP0002722_abnormal_immune_system | 0.87171187 |
| 84 | MP0003091_abnormal_cell_migration | 0.84966518 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.83636903 |
| 86 | MP0005165_increased_susceptibility_to | 0.83462214 |
| 87 | MP0003795_abnormal_bone_structure | 0.83443224 |
| 88 | * MP0000249_abnormal_blood_vessel | 0.83440377 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.83430235 |
| 90 | MP0002735_abnormal_chemical_nociception | 0.83019666 |
| 91 | MP0002168_other_aberrant_phenotype | 0.82760863 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.81464476 |
| 93 | MP0001958_emphysema | 0.81278215 |
| 94 | MP0008004_abnormal_stomach_pH | 0.78808630 |
| 95 | MP0003329_amyloid_beta_deposits | 0.78246746 |
| 96 | MP0001727_abnormal_embryo_implantation | 0.77845312 |
| 97 | MP0000490_abnormal_crypts_of | 0.77313125 |
| 98 | MP0000371_diluted_coat_color | 0.77127229 |
| 99 | MP0003186_abnormal_redox_activity | 0.77068583 |
| 100 | MP0001663_abnormal_digestive_system | 0.76768796 |
| 101 | MP0005535_abnormal_body_temperature | 0.74633255 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.72174728 |
| 103 | MP0005647_abnormal_sex_gland | 0.71876814 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.70917578 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.69266901 |
| 106 | MP0003279_aneurysm | 0.67671281 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.66212552 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.64944368 |
| 109 | MP0009840_abnormal_foam_cell | 0.64029698 |
| 110 | MP0005023_abnormal_wound_healing | 0.63894894 |
| 111 | MP0005171_absent_coat_pigmentation | 0.63153167 |
| 112 | MP0008260_abnormal_autophagy | 0.62723460 |
| 113 | MP0002090_abnormal_vision | 0.62016035 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.61708319 |
| 115 | MP0008874_decreased_physiological_sensi | 0.61123262 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.59057461 |
| 117 | MP0003634_abnormal_glial_cell | 0.58348523 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.57982301 |
| 119 | MP0003633_abnormal_nervous_system | 0.57276179 |
| 120 | MP0001542_abnormal_bone_strength | 0.57182899 |
| 121 | MP0008873_increased_physiological_sensi | 0.56993839 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.55144266 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55031501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.36834940 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.54065588 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.37069413 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.15829723 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.21943244 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.80753212 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.59667758 |
| 8 | Obstructive lung disease (HP:0006536) | 4.51485409 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.51485409 |
| 10 | Stomatitis (HP:0010280) | 4.42037324 |
| 11 | Loss of speech (HP:0002371) | 4.38483956 |
| 12 | Recurrent skin infections (HP:0001581) | 4.36159537 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.21361077 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.17371815 |
| 15 | Mutism (HP:0002300) | 4.09706732 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.09538041 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.09538041 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.93746494 |
| 19 | Gingivitis (HP:0000230) | 3.92697471 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.60497100 |
| 21 | Orchitis (HP:0100796) | 3.48216706 |
| 22 | Recurrent viral infections (HP:0004429) | 3.47784512 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43126274 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.42997302 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.38394072 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.36828159 |
| 27 | Optic neuritis (HP:0100653) | 3.36828159 |
| 28 | Myositis (HP:0100614) | 3.31730297 |
| 29 | Amyloidosis (HP:0011034) | 3.30248000 |
| 30 | Vasculitis (HP:0002633) | 3.09895246 |
| 31 | Basal ganglia calcification (HP:0002135) | 3.05417951 |
| 32 | Apathy (HP:0000741) | 3.04933008 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99220814 |
| 34 | Diminished motivation (HP:0000745) | 2.97029005 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.96711052 |
| 36 | Agnosia (HP:0010524) | 2.89982625 |
| 37 | Hematochezia (HP:0002573) | 2.85845082 |
| 38 | Spondylolisthesis (HP:0003302) | 2.81068565 |
| 39 | Neuronal loss in central nervous system (HP:0002529) | 2.79121442 |
| 40 | Prostate neoplasm (HP:0100787) | 2.78202924 |
| 41 | Nuclear cataract (HP:0100018) | 2.76805812 |
| 42 | Meningitis (HP:0001287) | 2.76560284 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.70919142 |
| 44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.70547819 |
| 45 | Cellulitis (HP:0100658) | 2.69718409 |
| 46 | Osteomyelitis (HP:0002754) | 2.67697501 |
| 47 | Purpura (HP:0000979) | 2.66709557 |
| 48 | Periodontitis (HP:0000704) | 2.66678790 |
| 49 | Urticaria (HP:0001025) | 2.63146753 |
| 50 | Petechiae (HP:0000967) | 2.62538221 |
| 51 | Myocardial infarction (HP:0001658) | 2.59196902 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.58784813 |
| 53 | Inappropriate behavior (HP:0000719) | 2.58528991 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.58006209 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58006209 |
| 56 | Progressive neurologic deterioration (HP:0002344) | 2.55380981 |
| 57 | Gingival bleeding (HP:0000225) | 2.53085022 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53035461 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53035461 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53035461 |
| 61 | Complement deficiency (HP:0004431) | 2.52513550 |
| 62 | Polyneuropathy (HP:0001271) | 2.51678273 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.47509711 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47509711 |
| 65 | Increased serum ferritin (HP:0003281) | 2.47395051 |
| 66 | Gangrene (HP:0100758) | 2.46243521 |
| 67 | Axonal loss (HP:0003447) | 2.45922133 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.44942229 |
| 69 | Hemoptysis (HP:0002105) | 2.42748072 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41393630 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41393630 |
| 72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41393630 |
| 73 | Joint hemorrhage (HP:0005261) | 2.40775826 |
| 74 | Increased IgM level (HP:0003496) | 2.40486933 |
| 75 | Absent frontal sinuses (HP:0002688) | 2.40413523 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.39773818 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38356733 |
| 78 | Episodic fever (HP:0001954) | 2.37665851 |
| 79 | Leukocytosis (HP:0001974) | 2.35481937 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.35030952 |
| 81 | Pustule (HP:0200039) | 2.33988773 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33893169 |
| 83 | Arterial thrombosis (HP:0004420) | 2.33292820 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.32803063 |
| 85 | Tetany (HP:0001281) | 2.31003610 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.28715035 |
| 87 | Abnormality of the periventricular white matter (HP:0002518) | 2.24692398 |
| 88 | Disinhibition (HP:0000734) | 2.21613210 |
| 89 | Cheilitis (HP:0100825) | 2.19847473 |
| 90 | Peritonitis (HP:0002586) | 2.18901611 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.18167650 |
| 92 | Increased CSF protein (HP:0002922) | 2.17431565 |
| 93 | Porencephaly (HP:0002132) | 2.16586897 |
| 94 | Nausea (HP:0002018) | 2.12878854 |
| 95 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12530929 |
| 96 | Abnormality of complement system (HP:0005339) | 2.11840699 |
| 97 | Retinal atrophy (HP:0001105) | 2.11795121 |
| 98 | Tetraparesis (HP:0002273) | 2.11138172 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.11045238 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 2.10856850 |
| 101 | Bone pain (HP:0002653) | 2.10275548 |
| 102 | Menorrhagia (HP:0000132) | 2.08341352 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06766345 |
| 104 | Arterial tortuosity (HP:0005116) | 2.06352910 |
| 105 | Glomerulonephritis (HP:0000099) | 2.06065975 |
| 106 | Global brain atrophy (HP:0002283) | 2.04666106 |
| 107 | Esophageal neoplasm (HP:0100751) | 2.03654762 |
| 108 | Neoplasm of head and neck (HP:0012288) | 2.03654762 |
| 109 | Personality changes (HP:0000751) | 2.00255004 |
| 110 | Pathologic fracture (HP:0002756) | 2.00178409 |
| 111 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98582983 |
| 112 | Hypoplasia of the fovea (HP:0007750) | 1.98582983 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.98331497 |
| 114 | Joint swelling (HP:0001386) | 1.97985693 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.97816145 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.97537669 |
| 117 | Metaphyseal irregularity (HP:0003025) | 1.96392426 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.95326380 |
| 119 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.93001601 |
| 120 | Restrictive lung disease (HP:0002091) | 1.92941807 |
| 121 | Supranuclear gaze palsy (HP:0000605) | 1.92463283 |
| 122 | Dementia (HP:0000726) | 1.92362477 |
| 123 | Progressive visual loss (HP:0000529) | 1.89874194 |
| 124 | Memory impairment (HP:0002354) | 1.88748109 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.88745494 |
| 126 | Aortic dissection (HP:0002647) | 1.87585600 |
| 127 | Anorexia (HP:0002039) | 1.85639446 |
| 128 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.84990007 |
| 129 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83883787 |
| 130 | Nephritis (HP:0000123) | 1.83120608 |
| 131 | Vascular tortuosity (HP:0004948) | 1.82020632 |
| 132 | Vertigo (HP:0002321) | 1.81801011 |
| 133 | Eosinophilia (HP:0001880) | 1.81100821 |
| 134 | Fused cervical vertebrae (HP:0002949) | 1.80632185 |
| 135 | Peripheral demyelination (HP:0011096) | 1.79884628 |
| 136 | Abnormality of the pericardium (HP:0001697) | 1.79070113 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.78907291 |
| 138 | Abnormality of T cells (HP:0002843) | 1.77783474 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.76824131 |
| 140 | Arthralgia (HP:0002829) | 1.76584846 |
| 141 | Abnormality of the endocardium (HP:0004306) | 1.76201065 |
| 142 | Conjunctival telangiectasia (HP:0000524) | 1.75296755 |
| 143 | Thick nail (HP:0001805) | 1.72985103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.56019647 |
| 2 | MAP3K14 | 4.24484772 |
| 3 | RIPK4 | 3.50042970 |
| 4 | BLK | 3.37728776 |
| 5 | IRAK4 | 3.34785757 |
| 6 | TBK1 | 3.27170472 |
| 7 | MST4 | 2.98180677 |
| 8 | DDR2 | 2.75020024 |
| 9 | PBK | 2.73992296 |
| 10 | TXK | 2.45125200 |
| 11 | STK24 | 2.32909193 |
| 12 | IKBKE | 2.27312241 |
| 13 | IKBKB | 2.22496109 |
| 14 | MAP4K1 | 2.17573998 |
| 15 | JAK3 | 2.13388760 |
| 16 | ERN1 | 2.07095355 |
| 17 | PDK2 | 2.01683895 |
| 18 | PIM2 | 1.99317334 |
| 19 | TGFBR2 | 1.93895970 |
| 20 | PRPF4B | 1.82040070 |
| 21 | MST1R | 1.73278758 |
| 22 | KIT | 1.72067084 |
| 23 | STK38L | 1.64501888 |
| 24 | TYK2 | 1.59350250 |
| 25 | EPHB1 | 1.54717830 |
| 26 | JAK1 | 1.54636474 |
| 27 | RPS6KA4 | 1.46007032 |
| 28 | TAOK2 | 1.43152334 |
| 29 | NTRK1 | 1.39967793 |
| 30 | MOS | 1.39151885 |
| 31 | BMX | 1.38266856 |
| 32 | PIM1 | 1.37001385 |
| 33 | ACVR1B | 1.35219719 |
| 34 | CDC42BPA | 1.33999725 |
| 35 | CHUK | 1.33008665 |
| 36 | TAOK1 | 1.31472669 |
| 37 | MAP3K13 | 1.31100142 |
| 38 | TAOK3 | 1.27723630 |
| 39 | TRPM7 | 1.21874961 |
| 40 | STK4 | 1.21762239 |
| 41 | EPHA3 | 1.20200955 |
| 42 | NEK9 | 1.16120913 |
| 43 | SYK | 1.15942281 |
| 44 | ABL2 | 1.15468560 |
| 45 | CSK | 1.15264782 |
| 46 | LATS2 | 1.13881006 |
| 47 | ADRBK2 | 1.13692237 |
| 48 | HCK | 1.12349031 |
| 49 | NME2 | 1.11427721 |
| 50 | ZAP70 | 1.08860110 |
| 51 | EIF2AK2 | 1.08579567 |
| 52 | OBSCN | 1.07596229 |
| 53 | BTK | 1.00419705 |
| 54 | MARK3 | 0.99247101 |
| 55 | IRAK1 | 0.95109069 |
| 56 | TEC | 0.94892591 |
| 57 | LYN | 0.94004115 |
| 58 | TTN | 0.92639583 |
| 59 | JAK2 | 0.90201962 |
| 60 | CLK1 | 0.88741777 |
| 61 | BMPR2 | 0.88368815 |
| 62 | SIK3 | 0.82973751 |
| 63 | GRK7 | 0.79086651 |
| 64 | LCK | 0.79045502 |
| 65 | ERBB3 | 0.77892611 |
| 66 | CAMKK2 | 0.74170157 |
| 67 | IRAK2 | 0.72001089 |
| 68 | STK10 | 0.70748276 |
| 69 | PAK4 | 0.69272191 |
| 70 | FGR | 0.67968699 |
| 71 | CAMK1D | 0.67610559 |
| 72 | CDK6 | 0.65405655 |
| 73 | ABL1 | 0.65345369 |
| 74 | ARAF | 0.65276696 |
| 75 | EGFR | 0.64468314 |
| 76 | STK3 | 0.63590439 |
| 77 | PIK3CG | 0.63473832 |
| 78 | MATK | 0.60932577 |
| 79 | MAP3K12 | 0.60657223 |
| 80 | PRKCD | 0.60364928 |
| 81 | FGFR3 | 0.59244267 |
| 82 | MAP3K5 | 0.57383854 |
| 83 | YES1 | 0.55495853 |
| 84 | TYRO3 | 0.54821108 |
| 85 | FES | 0.53093459 |
| 86 | PDGFRA | 0.50254498 |
| 87 | MAP3K11 | 0.49614012 |
| 88 | MAP3K1 | 0.49172890 |
| 89 | RPS6KA6 | 0.46328289 |
| 90 | RIPK1 | 0.46252525 |
| 91 | DAPK2 | 0.46034268 |
| 92 | DAPK3 | 0.44479516 |
| 93 | ERBB4 | 0.44349682 |
| 94 | MYLK | 0.42744514 |
| 95 | MAP2K3 | 0.42059583 |
| 96 | MAP3K2 | 0.41925526 |
| 97 | PDGFRB | 0.41307666 |
| 98 | ITK | 0.40206309 |
| 99 | MAP3K3 | 0.38615099 |
| 100 | PDPK1 | 0.38107804 |
| 101 | CSF1R | 0.37825294 |
| 102 | CAMKK1 | 0.36913150 |
| 103 | MET | 0.36813880 |
| 104 | NLK | 0.36313640 |
| 105 | PDK1 | 0.35946510 |
| 106 | RPS6KA5 | 0.32523894 |
| 107 | PRKCQ | 0.31659986 |
| 108 | KSR2 | 0.30234041 |
| 109 | NUAK1 | 0.27844815 |
| 110 | RPS6KA2 | 0.26813530 |
| 111 | PTK6 | 0.26697579 |
| 112 | MAPKAPK2 | 0.26477211 |
| 113 | NEK6 | 0.26144700 |
| 114 | MAP2K6 | 0.25862900 |
| 115 | INSR | 0.25391624 |
| 116 | TESK2 | 0.25290803 |
| 117 | LRRK2 | 0.25089089 |
| 118 | MAPK4 | 0.24708620 |
| 119 | FYN | 0.23287870 |
| 120 | GSK3A | 0.22843811 |
| 121 | EPHB2 | 0.21954476 |
| 122 | SRC | 0.21913837 |
| 123 | SGK1 | 0.21760146 |
| 124 | RPS6KC1 | 0.18486349 |
| 125 | RPS6KL1 | 0.18486349 |
| 126 | CAMK2G | 0.18014034 |
| 127 | KSR1 | 0.17563320 |
| 128 | CSNK1A1L | 0.16948351 |
| 129 | FER | 0.16614191 |
| 130 | IGF1R | 0.16404331 |
| 131 | TESK1 | 0.15768044 |
| 132 | MAP3K9 | 0.15600787 |
| 133 | PRKAA2 | 0.15245198 |
| 134 | PKN1 | 0.14838661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.56395420 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.18297299 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87421804 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.76956268 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.71261577 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.56191294 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.55878186 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55654898 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.54897061 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.43153418 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.36556732 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30286843 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14210010 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11916773 |
| 15 | * Phagosome_Homo sapiens_hsa04145 | 2.08089791 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05775289 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.96056969 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90218337 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.86164553 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86068704 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.85194772 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84846599 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.84369381 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77587754 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.69992865 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57731609 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.56715576 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52345040 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47243664 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39588192 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.38229024 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35812288 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.29590354 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27586841 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.27478541 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27394885 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27235512 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26644667 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24700095 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17173816 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16398075 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14541739 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.13116106 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05444870 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02610089 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.00440848 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 0.99758585 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99361387 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97848270 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97815356 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90577652 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84159543 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83726462 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82838528 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80945389 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79603315 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72976094 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.71861322 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.68727671 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64279441 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63278002 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62988421 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60907767 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58716998 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58449369 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.57494637 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57023234 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54883907 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54469849 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54077362 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51060567 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50862600 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50339125 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49756769 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48847389 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45359964 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44368070 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42916072 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42704386 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.41397297 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.39896789 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39307428 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38326349 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37723621 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36967271 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33905025 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33342570 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32679561 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32224110 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29158254 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28754241 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27309363 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26853529 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25627638 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25160974 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24877116 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24103304 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22607763 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22600097 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22565350 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22275387 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.22123745 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21906437 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21576972 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21253705 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21158506 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.21000621 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20861657 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20465878 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19603889 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.18825502 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16935881 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16436982 |
| 114 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11954348 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11534107 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10500342 |

